GILEAD SCIENCES, INC.: RCUS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GILEAD SCIENCES, INC. on RCUS, newest first. How the timeline and the estimate are built.
GILEAD SCIENCES, INC. held 31,424,760 RCUS shares at 2026-09-30 per its 13F-HR filed 2026-11-06.
the latest 13F is the newest step
- period ended2026-09-3013F 31,424,760 sharesChange vs previous 13F 0 shares
55.45% of the 13F portfolio, value $811,701,551.
13F-HR 0001123292-26-001479 filed by GILEAD SCIENCES, INC.
Accepted , ingested - period ended2026-06-3013F 31,424,760 sharesChange vs previous 13F 0 shares
58.76% of the 13F portfolio, value $968,825,351.
13F-HR 0001123292-26-001034 filed by GILEAD SCIENCES, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 31,424,760 sharesChange vs previous 13F 0 shares
32.05% of the 13F portfolio, value $678,774,816.
13F-HR 0001123292-26-000642 filed by GILEAD SCIENCES, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 31,424,760 sharesChange vs previous 13F 0 shares
38.69% of the 13F portfolio, value $748,852,031.
13F-HR 0001123292-26-000164 filed by GILEAD SCIENCES, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 31,424,760 sharesChange vs previous 13F 0 shares
23.86% of the 13F portfolio, value $427,376,736.
13F-HR 0001123292-25-000642 filed by GILEAD SCIENCES, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 31,424,760 sharesChange vs previous 13F 0 shares
19.98% of the 13F portfolio, value $255,797,546.
13F-HR 0001123292-25-000364 filed by GILEAD SCIENCES, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 31,424,760 sharesChange vs previous 13F +1,363,636 shares
20.88% of the 13F portfolio, value $246,684,366.
13F-HR 0001123292-25-000217 filed by GILEAD SCIENCES, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 30,061,124 sharesChange vs previous 13F not available
28.86% of the 13F portfolio, value $447,610,136.
13F-HR 0001123292-25-000079 filed by GILEAD SCIENCES, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).